Universitätsklinikum Frankfurt, Klinik für Psychiatrie, Psychosomatik und Psychotherapie
Welcome,         Profile    Billing    Logout  
 3 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Reif, Andreas
INTENSIFY SZ, NCT05958875: The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Recruiting
4
418
Europe
Clozapine, ATC code: N05AH02, Second-line Antipsychotics (treatment as usual)
Dr. Inge Winter, Universität Münster
Schizophrenia and Related Disorders, Early Treatment-Resistance
06/26
06/26
ENVISION, NCT05310071 / 2022-001671-14: A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Terminated
3
1027
Europe, Canada, Japan, US, RoW
Aducanumab, BIIB037, Aducanumab-avwa, Aduhelm, Placebo
Biogen, Biogen Idec Research Limited
Alzheimer's Disease
08/24
08/24
INTENSIFY MDD, NCT05973851: The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Recruiting
3
418
Europe
Esketamine Nasal Product, ATC code: N06AB10, Ketamine Hydrochloride, N01AX03, Esketamine hydrochloride, N015X14, Second-line Antidepressants
Dr. Inge Winter, Universität Münster
Major Depressive Disorder, Treatment Resistant Depression
06/26
06/26
INTENSIFY, NCT05603104: Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

Recruiting
3
1254
RoW
Clozapine, ATC code: N05AH02, Esketamine Nasal Product, ATC code: N06AB10, Escitalopram, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04, Second-line Antidepressants, Second-line Antipsychotics, Ketamine Hydrochloride, N01AX03, Esketamine hydrochloride, N015X14
Dr. Inge Winter, Universität Münster
Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression
06/26
06/26
INTENSIFY BD, NCT05973786: The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Recruiting
3
418
Europe
Escitalopram, ATC code: N06AB10, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04
Dr. Inge Winter, Universität Münster
Bipolar Depression
06/26
06/26
CL07-ORY-2001, NCT04932291 / 2020-003469-20: Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population

Completed
2
210
Europe, US, RoW
vafidemstat, ORY-2001, Placebo
Oryzon Genomics S.A.
Borderline Personality Disorder
10/23
11/23
SIMCODE, NCT04301271: Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression

Completed
2
161
Europe
Simvastatin 40mg, Zocor, C10AA01, Placebo oral tablet
Charite University, Berlin, Germany, NeuroCure Clinical Research Center, Charite, Berlin, University Medical Center Goettingen
Depressive Disorder, Major, Obesity
06/24
06/24
LANDSCAPE, NCT04943796: A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

Active, not recruiting
N/A
224
Europe, Canada
Takeda
Attention Deficit Hyperactivity Disorder (ADHD)
11/25
11/25

Download Options